Cholesterol Disorders

 
For the Statin-Intolerant or Statin-Unwilling Patient, Part 2: Other Pharmaceutical Options
July 18, 2023

For the 1 in 3 individuals with hyperlipidemia who can't or won't take a statin, preventive cardiologist Elizabeth Klodas, MD, details 3 alternative drug classes.

When Statins Are Not an Option, Part 1: Leverage Nutrition First
July 17, 2023

Preventive cardiologist Elizabeth Klodas, MD, reviews the essential elements of a plan of eating shown clinically to reduce hyperlipidemia.

The BMI vs Body Fat Debate: Study Suggests One-Third of People with Normal BMI are Obese
July 12, 2023

In Israel, where 60% of adults are overweight, new research prompts investigators to suggest that % body fat should replace BMI as the gold standard measure of obesity.

Choosing Between Guidelines: Statins for Primary CVD Prevention
July 11, 2023

In a recent comparison of guideline recommendations for initiating statin therapy in primary prevention, researchers found significant differences in the numbers who would benefit.

Daily Dose: Bempedoic Acid Reduces Risk for MACE in Primary Prevention Population
June 28, 2023

Your daily dose of clinical news you may have missed.

Bempedoic Acid Reduced Risk for MACE by 30% in Primary Prevention Population: CLEAR Outcomes Subanalysis
June 27, 2023

ADA 2023: The only nonstatin therapy to reduce risk for 4-point MACE in ASCVD may potentially find a role in primary prevention as well, though caution is advised.

FDA Approves Low-Dose Colchicine as First Anti-inflammatory Therapy to Reduce Cardiovascular Events
June 20, 2023

Colchicine 0.5 mg is associated with reduction in a wide range of CV events in patients already on statin therapy, supporting the long-held "anti-inflammatory" hypothesis.

Daily Dose: Bempedoic Acid Found Comparable to Statins for Lowering LDL-C
June 19, 2023

Your daily dose of clinical news you may have missed.

Bempedoic Acid Found Comparable to Statins for Lowering LDL-C, Reducing Major CV Event Risk
June 16, 2023

ENDO 2023: Treatment with bempedoic acid was found comparable to statin therapy in an analysis of the CLEAR Outcomes trial based on CTT Collaboration methodology.

Friday's 5 Quotes for Primary Care - 4-7-2023
April 07, 2023

High salt intake linked to coronary atherosclerosis; daily ETOH, even in small doses, is dangerous; statins don't increase muscle injury; and 2 more studies of note.